Aim. Local antibiotics released through a carrier is a commonly used technique to prevent infection in orthopaedic procedures. An interesting carrier in aseptic bone reconstructive surgery are bone chips impregnated with AB solution. Systemically administered Cefazolin (CFZ) is used for surgical site infection prophylaxis however in vitro study showed that fresh frozen and processed bone chips impregnated with CFZ solution completely release the CFZ within a few hours. On the other hand irradiated freeze-dried bone chips, treated with supercritical CO2 (scCO2) have been shown to be an efficient carrier for the antibiotics vancomycine or tobramycine. With this pilot study we wanted to investigate if CFZ solution impregnation of bone chips treated with scCO2 shows a more favorable release pattern of CFZ. Method. The bone chips were prepared using the standard scCO2 protocol and were impregnated with 100 mg/ml cefazolin at different timepoints during the process: before freeze drying (BC type A), after freeze drying (BC type B) and after gamma-irradiation. 0.5g of the impregnated bone grafts were incubated with 5ml of fetal calf serum (FCS) at 37°C. At 2, 4, 6, 8 and 24h of incubation 200µl of eluate was taken for analysis. After 24h the remaining FCS was removed, bone grafts were washed and new FCS (5ml) was added. Consecutive eluate samples were taken at 48, 72 and 96h of incubation. The concentration of CFZ in the eluates was measured with the validated UPLC-DAD method. Analysis was performed in triplicate. Results. The mean concentration of CFZ in the eluate obtained from BC type A incubated for 2h was higher compared to BC type B, respectively 581 mg/l and 297 mg/l. However, the elution profile is the same for both types: the CFZ concentration in the eluates drops within the first 24h from 581 mg/l to 365 mg/l (37%) for BC type A and from 297 mg/l to 132 mg/l (56%) for BC type B. After 24h no further significant CFZ release is seen. Impregnation of the bone chips before or after gamma irradiation did not affect this elution profile. Conclusions. Bone chips treated with scCO2 show a comparable elution pattern compared to non-scCO2 treated bone chips. AB release depends on the properties of the AB, making it impossible to copy the same impregnation protocol for different antibiotics. The stability of CFZ in solution at 37°C and its release are a major concern when establishing an impregnation protocol with CFZ

Introduction. Fibrous dysplasia is a pathological condition, where normal medullary bone is replaced by fibrous tissue and small, woven specules of bone. Fibrous dysplasia can occur in epiphysis, metaphysis or diaphysis. Occationally, biopsy is necessary to establish the diagnosis. We present a review of operative treatment using the Ilizarov technique. The management of tibial fibrous dysplasia in children are curettage or subperiosteal resection to extra periosteal wide resection followed by bone transport. Materials and Methods. A total of 18 patients were treated between 2010 – 2020; 12 patients came with pain and 6 with pain and deformity. All patients were treated by Ilizarov technique. Age ranges from 4–14 years. 12 patients by enbloc excision and bone transportation and 6 patients were treated by osteotomy at the true apex of the deformity by introducing the k/wires in the medullary cavity with stable fixation by Ilizarov device. The longest duration for bone transport was 16 weeks (14–20 weeks) for application, after deformity correction was 20 weeks. We have never used any kind of bone grafts. Results. All the 18 patients were treated successfully by Ilizarov compression distraction device. The patients with localized tibial pathology with deformity had the shortest period on the Ilizarov apparatus, 14 weeks. Conclusions. Preservation and bone regeneration by distraction histogenesis constitutes a highly conservative limb saving surgery. Patients with bone defects of <10 cm, a great deal of preserved healthy tissue and good prognosis are good candidates for these methods

Patients undergoing revision surgery of a primary total hip arthroplasty often exhibit bone loss and poor bone quality, which make achieving stable fixation and osseointegration challenging. Implant components coated in porous metals are used clinically to improve mechanical stability and encourage bone in-growth. We compared ultra-porous titanium coatings, known commercially as Gription and Porocoat, in an intra-articular model by press-fitting coated cylindrical implants into ovine femoral condyles and evaluating bone in-growth and fixation strength 4, 8 and 16 weeks post-operatively. Bilateral surgery using a mini-arthrotomy approach was performed on twenty-four Dorset-Rideau Arcott rams (3.4 ± 0.8 years old, 84.8 ± 9.3 kg) with Institutional Animal Care Committee approval in accordance with the Canadian Council on Animal Care. Cylindrical implants, 6.2 mm in diameter by 10 mm in length with surface radius of curvature of 35 mm, were composed of a titanium substrate coated in either Porocoat or Gription and press-fit into 6 mm diameter recipient holes in the weight-bearing regions of the medial (MFC) and lateral (LFC) femoral condyles. Each sheep received 4 implants; two Gription in one stifle (knee) and two Porocoat in the contralateral joint. Biomechanical push-out tests (Instron ElectroPuls E10000) were performed on LFCs, where implants were pushed out relative to the condyle at a rate of 2 mm/min. Force and displacement data were used to calculate force and displacement at failure, stiffness, energy, stress, strain, elastic modulus, and toughness. MFCs were fixed in 70% ethanol, processed undecalcified, and polished sections, approximately 70 µm thick (Exakt Micro Grinding system) were carbon-coated. Backscattered electron images were collected on a scanning electron microscope (Hitachi SU3500) at 5 kV and working distance of 5 mm. Bone in-growth within the porous coating was quantified using software (ImageJ). Statistical comparisons were made using a two-way ANOVA and Fisher's LSD post-hoc test (Statistica v.8). Biomechanical evaluation of the bone-implant interface revealed that by 16 weeks, Gription-coated implants exhibited higher force (2455±1362 N vs. 1002±1466 N, p=0.046) and stress (12.60±6.99 MPa vs. 5.14±7.53 MPa, p=0.046) at failure, and trended towards higher stiffness (11510±7645 N/mm vs. 5010±8374 N/mm, p=.061) and modulus of elasticity (591±392 MPa vs. 256±431 MPa, p=0.61). Similarly, by 16 weeks, bone in-growth in Gription-coated implants was approximately double that measured in Porocoat (6.73±3.86 % vs. 3.22±1.52 %, p=0.045). No statistically significant differences were detected at either 4 nor 8 weeks, however, qualitative observations of the exposed bone-implant interface, made following push-out testing, showed more bony material consistently adhered to Gription compared to Porocoat at all three time points. High variability is attributed to implant placement, resulting from the small visual window afforded during surgery, unique curvatures of the condyles, and presence of the extensor digitorum longus tendon which limited access to the LFC. Ultra-porous titanium coatings, know commercially as Gription and Porocoat, were compared for the first time in a challenging intra-articular ovine model. Gription provided superior fixation strength and bone in-growth, suggesting it may be beneficial in hip replacement surgeries where bone stock quality and quantity may be compromised

Aim. Treatment of infected and non-infected non-unions remain a major challenge after orthopedic fracture-related surgery. In clinical practice, several revision surgeries are usually required, including a radical debridement and exchange of implants, to control or even eradicate the infection to finally achieve bone healing. However, a clear treatment algorithm in clinical practice may be difficult to follow due to the heterogeneous patient population. Thus, so controlled settings for research purposes is better achieved in standardized animal studies. So far, there exists no multi-stage animal model that can be realistically transferred to the clinical situation in humans. The importance of such a model is obvious in order to be able to investigate different therapy concepts for infected and non-infected non unions. Methods. In 20 female Sprague-Dawley rats, a critical size defect by a femur osteotomy with 5 mm width was done. The periosteum at the fracture zone was cauterized proximal and distal to the osteotomy to achieve an hypovascularized situation. After randomization, 10 animals were intramedullary infected with a multisensible Staph. aureus strain (10. 3. CFU). After 5 weeks, a second surgery was performed with removing the K-wire, debridement of the osteotomy-gap and re-osteosynthesis with an angle-stable plate. After further 8 weeks all rats were euthanized and underwent biomechanical testing to evaluate bone consolidation or delayed union, respectively. Additional micro-CT analysis, histological, and histomorphometric analysis were done to evaluate bone consolidation or delayed union, respectively, by the score of Lane and Sandhu and to quantify callus formation and the mineralized area of the callus. Results. 5 weeks after the first surgery a non-union had formed in all septic and aseptic animals. According to the Lane and Sandhu score a significantly higher callus formation was found in the infected group. In all infected animals, the inoculated Staph. aureus strain was detected during the revision surgery. 8 weeks after the second surgery no bone healing could be detected in the µ-CT analysis in both groups and biomechanical testing showed a significant lower maximum torque in both groups as compared to the untreated contralateral femura. Conclusion. Here we show first results of a new two-stage pseudarthrosis animal model, which reflects a very realistic clinical situation of an infection-related non-union model. Based on this model, various therapeutic strategies in the treatment of infectious and non-infectious pseudarthrosis, such as the use of bone substitutes, can be evaluated in further studies

Over the past 15 years Anterior Approach (AA) THA has shown a dramatic increase in adoption by surgeons (over 30%) and choice by patients with a corresponding decrease in the percentage of hips performed with traditional posterior and lateral approaches. I began AA in 1996 in order to solve the classic problems of potential dislocation associated with posterior approach and potential abductor weakness associated with the lateral (Harding) approach. Surgeon education on AA began in 2013 and has accelerated since. AA is usually performed with the aid of an orthopaedic table which facilitates exposure though many cases are also performed on a standard operating table. Intraoperative image intensification has provided real-time feedback and accuracy for cup position leg length and offset and is facilitated by the supine position and a radiolucent orthopaedic table, however, AA can be performed without it. Earlier functional recovery with decreased post-operative pain is the best documented benefit of AA as well as decreased dislocation rate. My own point of view is to take advantage of a switch to AA to improve more than your surgical approach. Improve also hip biomechanics, cup position, ease of surgery, bone preparation, and soft tissue handling. A proven and repeatable technique and use of available technologies will facilitate this

Introduction. Few studies are published about total hip arthroplasties (THA) in Parkinson's disease as it is often considered as a contraindication for hip replacement. THA for fracture is reported as a high complication rate surgery. Regarding bone quality these cases are assimilated to elderly patients and cemented implants are generally preferred. However, due to the improved length and quality of life, we face more potential indications for joint replacement. The aim of this study is to report our experience of cementless dual mobility implants for primary THAs for osteoarthrosis and THA revisions focusing on the risks and benefits of surgery. Material and methods. 65 THA were performed in 59 patients (34 men, 25 women, mean age 73 years, 55–79). Mean latest follow-up was 8,3 years (4–14). Indications were 42 primary THA (osteoarthrosis) and 21 revisions (11 recurrent dislocation, 6 acetabular PE wear, 4 femoral loosening). Surgical approach was always antero-lateral. All patients were implanted with the same dual mobility cementless cup. The same cementless corail-type stem was used for primary THA cases. All the cemenless implants were hydroxyapatite coated. The disability caused by the disease was classified according to Hoehn and Yahr. (19 stage 1, 21 stage 2,16 stage 3). Results. 2 patients were lost for follow-up before 2 years. general complications were 3 pulmonary infection, 7 urinary tract infection, 12 cognitive impairment and 2 sacral pressure ulcer. A post-op. wound infection (E Coli) required an early revision in 2 cases without secondary consequencies (7 and 9 years follow-up). We did not observe early or late THA dislocation except in one case at 9 years follow-up (intraprosthetic dislocation due to an increase of ilio psoas muscle retraction requiring a revision of the dual mobility mechanism). We did not observe loosening cases of the cementless cup. 4 patients fell and fractured the femur. The cementless cup was not affected. 10 patients died. Good to excellent pain relief was achieved in 53/57cases at 2 years and in 40/47 cases at latest follow-up. The progression of neurological disability was observed in most of cases. At the latest follow-up for the 47 remaining patients, we had 5 stage 1, 12 stage 2, 21 stage 3,9 stage 4. Discussion. According to literature infection and dislocation are the main concerns for THA in Parkinson patients. This study does not report any trauma cases; this may explain the rather good results on a mean follow-up to more than 8 years. Nevertheless progression of Parkinson's disease is the rule, with significant disability or even death (10 /57 cases). Cementless fixation is possible even on the acetabular side. The poor bone quality of these patients was not an argument against hydroxyapatite coated implants. Conclusion. THA in Parkinson's disease is a challenging surgery due to associated comorbidity. For all patients the functional status improved in the early follow-up and declined with the disease progression. Cementless dual mobility cups and femoral stems can be used with a very low rate of mechanical complication

Dorr bone type is both a qualitative and quantitative classification. Qualitatively on x-rays the cortical thickness determines the ABC type. The cortical thickness is best judged on a lateral x-ray and the focus is on the posterior cortex. In Type A bone it is a thick convex structure (posterior fin of bone) that can force the tip of the tapered implant anteriorly – which then displaces the femoral head posteriorly into relative retroversion. Fractures in DAA hips have had increased fractures in Type A bone because of the metaphyseal-diaphyseal mismatch (metaphysis is bigger than diaphysis in relation to stem size). Quantitatively, Type B bone has osteoclastic erosion of the posterior fin which proceeds from proximal to distal and is characterised by flattening of the fin, and erosive cysts in it from osteoclasts. A tapered stem works well in this bone type, and the bone cells respond positively. Type C bone has loss of the entire posterior fin (stove pipe bone), and the osteoblast function at a low level with dominance of osteoclasts. Type C is also progressive and is worse when both the lateral and AP views show a stove pipe shape. If just the lateral x-ray has thin cortices, and the AP has a tapered thickness of the cortex a non-cemented stem will work, but there is a higher risk for fracture because of weak bone. At surgery Type C bone has “mushy” cancellous bone compared to the hard structure of type A. Tapered stems have high risk for loosening because the diaphysis is bigger than the metaphysis (opposite of Type A). Fully coated rod type stems fix well, but have a high incidence of stress shielding. Cemented fixation is done by surgeons for Type C bone to avoid fracture, and insure a comfortable hip. The large size stem often required to fit Type C bone causes an adverse-stem-bone ratio which can cause chronic thigh pain. I cement patients over age 70 with Type C bone which is most common in women over that age

Aim. To prevent infections after orthopaedic surgery, intravenous antibiotics are administered perioperatively. Cefazolin is widely used as the prophylactic antibiotic of choice. Systemic antibiotic therapy may however be less effective in longstanding surgery where bone allografts are used. Bone chips have been shown to be an effective carrier for certain types of antibiotics and may provide the necessary local antibiotic levels for prophylaxis. To be efficient a prolonged release is required. In contrast to vancomycin with proven efficient prolonged release from Osteomycin, this has not been described for cefazolin. We developed a protocol to bind cefazolin to bone chips by means of a hydrogel composed of proteins naturally present in the human body. Method. Three types of bone chips were evaluated: fresh frozen, decellularized frozen and decellularized lyophilized. Bone chips were incubated with 20 mg/ml cefazolin or treated with liquid hydrogel containing either 1 mg/ml fibrin or 1 mg/ml collagen and 20 mg/ml cefazolin. The cefazolin hydrogel was distributed in the porous structure by short vacuum treatment. Bone chips with cefazolin but without hydrogel were either incubated for 20 min- 4h or also treated with vacuum. Cefazolin elution of bone chips was carried out in fetal bovine serum and analysed by Ultra Performance Liquid Chromatography – Diode Array Detection. Results. Soaking of bone chips without hydrogel resulted in a quick release of cefazolin, which was limited to 4 hours. When vacuum was applied elution of >1 µg/ml cefazolin was measured for up to 36 hours. Combination with collagen hydrogel resulted in a higher cefazolin concentration released at 24 hours (3.9 vs 0.3 µg/ml), but not in a prolonged release. However, combination of decellularized frozen bone chips with fibrin hydrogel resulted in an initial release of 533 µg/ml followed by a gradual decline reaching the minimal inhibitory concentration for S. aureus at 72 hours (1.7 µg/ml), while not measurable anymore after 92 hours. Conclusions. Processed bone chips with hydrogel-cefazolin showed a markedly prolonged cefazolin release. When combined with a fibrin hydrogel, high initial peak levels of cefazolin were obtained, followed by a decreasing release over the following three days. This elution profile seems desirable, with high initial levels to maximize anti-bacterial action and low levels for a limited time to stimulate osteogenesis. Further preclinical studies are warranted to show effectiveness of hydrogel-cefazolin impregnated bone chips

Aims

The Precice intramedullary limb-lengthening system has demonstrated significant benefits over external fixation lengthening methods, leading to a paradigm shift in limb lengthening. This study compares outcomes following antegrade and retrograde femoral lengthening in both adolescent and adult patients.

Introduction. The number of total hip arthroplasties has been increasing worldwide, and it is expected that revision surgeries will increase significantly in the near future. Although reconstructing normal hip biomechanics with extensive bone loss in the revision surgery remains challenging. The custom−made acetabular component produced by additive manufacturing, which can be fitted to a patient's anatomy and bone defect, is expected to be a predominant reconstruction material. However, there have been few reports on the setting precision and molding precision of this type of material. The purpose of this study was to validate the custom−made acetabular component regarding postoperative three−dimensional positioning and alignment. Methods. Severe bone defects (Paprosky type 3A and 3B) were made in both four fresh cadaveric hip joints using an acetabular reamer mimicking clinical cases of acetabular component loosening or osteolysis in total hip arthroplasty. On the basis of computed tomography (CT) after making the bone defect, two types of custom−made acetabular components (augmented type and tri−flanged type) that adapted to the bone defect substantially were produced by an additive manufacturing machine. A confirmative CT scan was taken after implantation of the component, and then the data were installed in an analysis workstation to compare the postoperative component position and angle to those in the preoperative planning. Results. The mean absolute deviations of the center of the hip joint between preoperative planning and the actual component position in the augmented type were 0.7 ± 0.4 mm for the horizontal position, 0.2 ± 0.1 mm for the vertical position, and 0.5 ± 0.3 mm for the antero−posterior position. The mean absolute deviations of the center of the hip joint in the tri−flanged type in the horizontal, vertical, and antero−posterior positions were 1.0 ± 0.4 mm, 0.4 ± 0.2 mm, 0.3 ± 0.1 mm, respectively. The mean absolute deviations of the component angle were 3.5° ± 0.9° at inclination and 2.0° ± 1.7° at anteversion in the augmented type and 0.6° ± 0.5° at inclination and 0.9° ± 0.3° at anteversion in the tri−flanged type. Conclusion. Since custom−made orthopaedic implants produced by additive manufacturing can support individual anatomy and bone defect, this type of implant is expected to be applied to revision surgery and bone tumor surgery for severe bone defects. The present study demonstrated that preoperative planning of the center of the hip joint was successfully reproduced after the implantation of both types of custom−made acetabular components. In the tri−flanged type, better satisfactory results were provided in the component position and angle by comparing the past CAOS tools such as a surgical navigation system and a patient−specific guide. There is scope for further improvement, but the custom−made acetabular component produced by additive manufacturing may become very useful reconstruction material in hip revision surgeries. Problems to be addressed in the future include the improvement of the reproducibility of the preoperative planning and investigation of long−term clinical results

Aim. The incidence of posttraumatic osteomyelitis (PTO) is increasing in spite of new surgical techniques and development of new antimicrobial therapies. It has been difficult to assess outcomes of PTO because of the numerous risk factors involving the patients, trauma characteristics, surgical conditions, diversity of etiologic agents and long period of follow-up required to determine the effects of any treatment. We aim to identify factors predisposing to develop recurrence of chronic PTO. Method. Between August 2007 and August 2012, a single-centre prospective cohort study was carried out among 193 patients with PTO following orthopaedic surgery. Bone and soft tissues were collected for cultures and PTO was defined according to CDC/NHSN criteria. Patient, injury, surgery-associated variables and microbiological records were identified for potential risk factors associated to recurrence of PTO. Univariate and multivariable analyses using logistic regression were performed, and p <0.05 was considered significant. Results. We analysed 192 patients with PTO, of which 38 (19.8%) had recurrence. One hundred and thirty-two (68.8%) patients were men and 25.9% were over 60 years of age. High-energy trauma due to road traffic accidents occurred in 57% of our population and 29.7% suffering fall from height. Open fractures were diagnosed in 37.8% of patients and 39.9% underwent more than one surgical debridement. Factors associated to recurrence in the multivariable analysis were age 61–80 years and above 80 years [hazard ratio (HR) = 6.086, 95% confidence interval (CI) = 2.459;15.061, p = <0.001] and [HR = 9.975 (95% CI = 3.591;27.714), p = <0.001], need for intraoperative blood transfusion[HR = 2.239 (95% CI = 1.138;4.406), p = 0.020], and bone and soft tissue positive culture for Pseudomonas aeruginosa[HR = 2.700 (95% CI = 1.370;5.319), p = 0.004]. When P. aeruginosa was the recovered pathogen, disease-free survival was lower than of Staphylococcus aureus and Enterococcus spp, p = 0.002. In terms of age, disease-free survival was of 38 months for patients 61 to 80 years and of 17 months for more than 80 years; p <0.001. Conclusions. Risk factors associated with recurrence of the PTO are difficult to be measured e the present study revealed that elderly patients, the need for intraoperative blood transfusion and P. aeruginosa culture were independently associated with recurrence of PTO

Purpose of study:. The purpose of the study is to evaluate the changes in peri-prosthetic bone mineral density following cemented and cementless total hip arthroplasty over a follow up period of 1 year. Description of methods:. Ethics approval was sought and granted by the South African Medical Association Research Ethics Committee (SAMAREC). Patient consent for participation was obtained. Recruitment of the cohort took place over 2 years. Patients received an uncemented (Synergy) or cemented (Spectron) prosthesis as clinically appropriate. Functional status according to the University of California Los Angeles activity scale (UCLA scale) and bone mineral density as measured by Dual Energy X-ray Absorptiometry (DEXA) was assessed pre-operatively and at 3 months, 6 months and 12 months post-operatively. An independent Contract Research Organisation was used to monitor the site. Summary of results:. As at August 2010, 59 unique patients had undergone 59 hip replacements, and 7 patients (8.5%) were still due their 12 month evaluation. The mean UCLA scored showed a marked and steady improvement post-operatively, with most of the gain demonstrated by 3 months. When evaluating all patients, the mean pre-operative values for Gruen Zones 2, 4, and Net were significantly lower than the mean 12 month values. When evaluating patients who received the uncemented prosthesis (n=40), the mean pre-operative values for Gruen Zones 2 and Net were significantly lower than the mean 12 month values, and the mean pre-operative values for Gruen Zones 1 and 3 were significantly higher than the mean 12 month values. When evaluating patients who received the cemented prosthesis (n=19), the median pre-operative values for Gruen Zones 1, 2, 3, 4, 7 and Net were significantly lower than the median 12 month values. Conclusion:. At 1 year post surgery overall bone density showed a significant increase in both the cemented and uncemented cohort

INTRODUCTION. Trabecular Titanium™ is an innovative material characterised by an high open porosity and composed by multi-planar regular hexagonal cells. It is not a traditional coating and its tri-dimensional structure has been studied to optimise osteointegration. Furthermore, it has excellent mechanical properties, as a very high tensile and fatigue resistance and an elastic module very similar to the that of the trabecular bone. The aim of this study is to evaluate the osteointegration and bone remodelling measuring the longitudinal pattern of change in BMD around a cementless acetabular cup made from Trabecular Titanium™ (Delta TT cup, Lima Corporate, Italy) in primary total hip arthroplasty (THA). METHODS. Dual-energy x-ray absorptiometry (DEXA) analysis, radiographic evaluation on standard AP and lateral views and clinical evaluation with Harris Hip Score (HHS) and SF-36 were performed at 1 week, 3, 6, 12 months after surgery. RESULTS. Between February 2009 and June 2010, 72 patients underwent primary THA with Delta TT cup at 4 centres. There were 36 (50%) female and 36 (50%) male with an average age of 63 (range 39-75). Preliminary results include 72 patients with 56 at 3 months, 42 at 6 months and 28 at 12 months. The mean HHS improved from 48 points (range 14-79) preoperatively to 88 (range 74-100) at 3 months, to 94 (range 71-100) at 6 months and to 97 (range 94-100) at 12 months. SF-36 reported a progressive improvement of all domains. An initial transient decrease of the bone mineral density (BMD) occurred between 1 week and 3 months after surgery, then bone mass returns to baseline values after 6 months and increased at 12 months. No radiolucent lines nor osteolysis have reported and no revision occurred. There were 2 complications not related to the implant on study: one dislocation solved with a close reduction and one dislocation solved with a revision of the neck and the head, but not compromising the cup. CONCLUSIONS. Delta TT acetabular cup allows to obtain a very good primary stability, thanks to the high friction coefficient of the Trabecular Titanium™, followed by a good and fast osteointegration, as reported by early DEXA outcomes. Preliminary results showed also a very good clinical and functional improvement. Long-term follow-up is ongoing in order to prove these promising results

The treatment of fracture accompanied with bone defect remains a challenge in skeletal surgery. For bone defect, we have to give a material to support healing process. Some material is allograft given at second to sixth weeks to avoid osteoclastic activity. We try to give primary allograft and to prevent osteoclastic activity we use risedronat. Risedronate (Actonel(r)) is one of bisphosphonate group that decrease the turnover of the bone by activating apoptosis of osteoclast and increasing osteoblast activity. The aim of this paper is to evaluate radiologically and histologically result for the effect of the bone healing process for a fracture associated with bone defect which treated by a combination of fresh frozen allograft and risedronate (Actonel(r)). The design is an experimental study, Post Test Only Control Group Design, using adult male white rats spraque-dawley. Right open tibial osteotomies to create bone defect are performed surgically and put Kirschner wire as intramedularry fixation. Rats are divided into four groups, with six samples in each group. Group one with bone defect in 2 mm, group two with bone defect 2 mm and put fresh frozen allograft, group three with bone defect 2 mm and put fresh frozen allograft and given Actonel(r) 350g a week for two first week, and group four with bone defect 2 mm and put fresh frozen allograft and given Actonel(r) 350g a week for six week. Six weeks after implantation, the animals were sacrificed, and the tibia were evaluated by radiological and histological studies. Radiologically, there are significant different of relative bone healing result between ungiven risedronat group (group one and two) and given risedronat group (group three and four) (Kolmogorof smirnov test). Histological results by one way anova shows varians test was p = 0,168 (p > 0,05). Anova test was p = 0,000 (p < 0,05), post hoc Turkey HSD there was not significant different between group one and group two p = 0,969, between group one dan group four p = 0,634 (p > 0,05), between group two dan group four p = 0,634 (p > 0,05); a significant different between group one and group three p = p = 0,000 (p<0,05) between group two and group three p = 0,01 (p < 0,05), and group three and group four p=0,004 (p < 0,05). Risedronate (Actonel(r)) influence the healing process of two mm bone defect radiologically. By histologically, two first weeks given of risedronate at group three have a better result than groups one, two and four

The amount of bone loss due to implant failure, loosening, or osteolysis can vary greatly and can have a major impact on reconstructive options during revision total knee arthroplasty. Massive bone loss can threaten ligamentous attachments in the vicinity of the knee and may require use of components with additional constraint to compensate for associated ligamentous instability. Classification of bone defects can be helpful in predicting the complexity of the reconstruction required and in facilitating preoperative planning and implant selection. One very helpful classification of bone loss associated with TKA is the Anderson Orthopaedic Research Institute (AORI) Bone Defect Classification System. This system provides the means to compare the location and extent of femoral and tibial bone loss encountered during revision surgery. In general, the higher grade defects (Type IIb or III) on both the femoral and tibial sides are more likely to require stemmed components, and may require the use of either structural graft or large augments to restore support for currently available modular revision components. Custom prostheses were previously utilised for massive defects of this sort, but more recently have been supplanted by revision TKA component systems with or without special metal augments or structural allograft. Options for bone defect management are as follows: 1) fill with cement, 2) fill with cement supplemented by screws or K-wires, 3) Morsellised bone grafting (for smaller, especially contained cavitary defects), 4) Small segment structural bone graft, 5) Impaction grafting, 6) Large prosthetic augments (cones), 7) Massive structural allograft-prosthetic composites (APC), 8) Custom implants. It is very helpful for revision surgeons to have a variety of reconstructive options available, even despite a well thought-out preoperative plan. Preoperative planning is important but the plan that results may require alteration during the course of the surgery to accommodate bone defects which are either less or more severe than thought pre-operatively, and to adjust to variable quality and extent of host bone remaining, as this provides the mechanical platform for the reconstruction. Maximising support on intact host bone is a fundamental principle to successful reconstruction and frequently requires extending fixation to the adjacent diaphysis. Bone defect management during revision total knee arthroplasty can provide a wide range of challenges from relatively trivial problems with small defects manageable with cement or small amounts of cancellous graft to massive deficiencies that may defy reconstruction except with allograft prosthetic components or large segmental replacing tumor-type implants. The more common Type II deficiencies increasingly seen in the context of particulate driven osteolysis demand a wide range of implant and bone graft options so that an individualised reconstruction can be accomplished for that particular patient based on bone defect size, location, quality of bone remaining, ligamentous status, and anticipated patient demands

Introduction. Initial fixation of noncemented implants is critical to achieve a stable bone/implant interface during the first few months after surgery to potentiate bone in-growth and avoid aseptic loosening. Numerous reverse shoulder glenoid implant designs have been conceived in an attempt to improve implant performance and decrease the rate of aseptic glenoid loosening, commonly reported to be 5%. Design variations include: baseplate profile, baseplate size, backside geometry, center of rotation, surface finish and coatings, fixation screw diameters, number of fixation screw options, and type of screw fixation. However, little comparative biomechanical data exist to substantiate one design consideration over another. To that end, this study quantified glenoid fixation before and after cyclic loading of simulated abduction of 6 different reverse shoulder glenoid designs when secured to a low density polyurethane bone substitute block. Methods. A displacement test quantified fixation of 6 different reverse shoulder designs: 38 mm Equinoxe standard offset (EQ), 38 mm Equinoxe lateral offset (EQL), 36 mm Depuy Delta III (DRS), 36 mm Zimmer, (ZRS), 32 mm neutral DJO RSP (DJO), and a 36 mm Tornier BIO-RSA (BIO), secured to a 0.24 g/cm. 3. polyurethane block as a shear (357 N) and compressive (50 N) load was applied before and after cyclic loading. (Figure 1) Glenoid displacement was measured relative to the block using dial indicators in the directions of the applied loads along the superior/inferior axis. A cyclic test rotated each glenosphere (n = 7 for each design) about a 55° arc of abduction at 0.5 Hz for 10k cycles as 750N was constantly applied. (Figure 2) Each implant was cycled using a 145° humeral liner of the appropriate diameter to ensure each device is subjected to the same shear load. A two-tailed unpaired student's t-test was used to compare pre- and post-cyclic mean displacements between designs; p < 0.05 denotes significance. Results. The average pre-cyclic displacement of the EQ, EQL, DRS, ZRS, DJO, and BIO devices was 181, 137, 186, 381, 238, 232 microns, respectively. The average post-cyclic displacement of the EQ, EQL, DRS, DJO, and BIO devices was 186, 129, 189, 368, 249 microns, respectively. During the cyclic test, 6 of 7 ZRS devices failed at an average of 2603 cycles, 1 of 7 DJO failed at 7342 cycles, and 4 of 7 BIO devices failed at an average of 2926 cycles. All 7 of the EQ, EQL, and DRS devices remained well fixed throughout cyclic loading. Discussion and Conclusions. The results of this study demonstrate significant difference in fixation associated 6 different reverse shoulder designs. Despite many similarities in geometry between these designs, significant differences in fixation were observed between nearly every implant design tested. This suggests that subtle changes in glenoid baseplate design can dramatically impact fixation, particularly in low density bone substitutes which are intended to simulate the bone quality of the recipient population for reverse shoulders. Future work should attempt to isolate which design parameters are the most critical contributors for initial fixation and ultimately, long-term stability

Introduction. Fracture non-union is a devastating cause of patient morbidity. The cost of NU treatment ranges from £7,000 to £79,000. With an estimated 11,700 cases in the UK pa the financial implications are huge, potentially costing several hundreds of million of pounds annually. Successful outcome in the management of non-union is based upon correctly identifying the underlying cause(s) and addressing them appropriately. Aim. The aim of this study was to assess the causative factors in non-union in order to optimize the management of non-union. The causes of NU were categorized into 4 groups (infection, dead bone/gap, host factors, mechanical). Method. 100 consecutive patients who had surgery for long bone non-union were analysed. Information was obtained from the patient clinic visits, notes, radiographs and laboratory results. The cause(s) of the non-union were identified, recorded and divided into 4 groups; host, mechanical, dead bone/gap at NU site and infection. Results. The mean age at time of injury was 41.4(±16.7)years; male/female ratio was 3:1, 80% were lower limb (52% of all cases were tibial). 69% were high energy, 38% were open. 26% of patients had a single attributable cause, 59% had two causes, 14% had three causes and one had all four. Mechanical causation was found in 56% of cases, dead bone/gap in 50%, host factors in 44%, infection in 40% of patients. 5.7% of the infections were unexpected new/occult positive findings. 73% of patients with previously treated infection but without ongoing infection had multiple positive cultures. Conclusion/discussion. Surgical procedures for non-union often address a single aspect yet 74% had more than one attributable cause. With a 6% occult infection rate multiple tissue samples for microbiology and pathology investigation should be carried out routinely in every patient with non-union. The multi-factorial nature of non-union makes meticulous patient assessment vital to maximise the chance of treatment success

INTRODUCTION. Allograft reconstruction after resection of primary bone sarcomas has a non-union rate of approximately 20%. Achieving a wide surface area of contact between host and allograft bone is one of the most important factors to help reduce the non-union rate. We developed a novel technique of haptic robot-assisted surgery to reconstruct bone defects left after primary bone sarcoma resection with structural allograft. METHODS. Using a sawbone distal femur joint-sparing hemimetaphyseal resection/reconstruction model, an identical bone defect was created in six sawbone distal femur specimens. A tumor-fellowship trained orthopedic surgeon reconstructed the defect using a simulated sawbone allograft femur. First, a standard, ‘all-manual’ technique was used to cut and prepare the allograft to best fit the defect. Then, using an identical sawbone copy of the allograft, the novel haptic-robot technique was used to prepare the allograft to best fit the defect. All specimens were scanned via CT. Using a separately validated technique, the surface area of contact between host and allograft was measured for both (1) the all-manual reconstruction and (2) the robot-assisted reconstruction. All contact surface areas were normalized by dividing absolute contact area by the available surface area on the exposed cut surface of host bone. RESULTS. The mean area of contact between host and allograft bone was 24% (of the available host surface area) for the all-manual group and 76% for the haptic robot-assisted group (p=0.004). CONCLUSIONS. This is the first report to our knowledge of using haptic robot technology to assist in structural bone allograft reconstruction of defects left after primary bone tumor resection. The findings strongly indicate that this technology has the potential to be of substantial clinical benefit. Further studies are warranted

Introduction. The purpose of this study was to establish whether men and women with a fragility hip fracture were equally investigated and treated for osteoporosis. Methods. A retrospective review was carried out including 91 patients (48 females, 43 males) who were admitted with a fragility hip fracture between March 2003 and April 2004. Data about age, sex, investigations and medication were collected from the case notes, GP surgeries and the bone densitometry database. Investigations and treatment were compared with current guideline recommendations (SIGN 2003, NICE 2005). Data were analysed using SPSS Version 13.0. Results. According to the guidelines patients < 75 years of age should be investigated and patients > 75 years should be treated for osteoporosis. In our review 33% of women and only 8% of men < 75 years were investigated with a DEXA scan following their hip fracture (Fishers Exact Test, p = 0.32). In patients > 75 years 25% of women and only 6% of men were treated with bisphosphonates (Chi-square = 4.18, p < 0.05). There was also a statistically significant difference in overall treatment including bisphosphonates and calcium/vitamin D between the sexes (Chi-square = 6.81, p < 0.05). Conclusion. This study shows that there is clearly a need for improvement in secondary prevention of fragility fractures in both sexes, but men are significantly less likely to be investigated and treated than women. It is important to include recommendations for men in future guidelines and increase the awareness of male osteoporosis. This is of particular importance as men have a higher morbidity and mortality following hip fractures than women. Orthopaedic surgeons should therefore take on responsibility for these fracture patients and ensure that the process of secondary prevention is initiated

Aims

Chronic osteomyelitis may recur if dead space management, after excision of infected bone, is inadequate. This study describes the results of a strategy for the management of deep bone infection and evaluates a new antibiotic-loaded biocomposite in the eradication of infection from bone defects.